Attention Deficit Hyperactivity Disorder Market Insights, Epidemiology Facts, Segmentation, and Forecast Report 2032

The Attention deficit hyperactivity disorder market report provides an edge while developing business strategies, by understanding trends shaping and driving the global Attention deficit hyperactivity disorder market. A detailed review of the historical and forecasted Attention deficit hyperactivity disorder market is included in the report, covering drug outreach in the 7MM.


Attention deficit hyperactivity disorder Overview

Attention-deficit/hyperactivity disorder (ADHD) is a brain disorder marked by an ongoing pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development. It is a group of behaviors and is also called as attention deficit disorder (ADD). It is a behavioral disorder that includes symptoms such as inattentiveness, hyperactivity, and impulsiveness.


Get Access to a Free Copy of Our Latest Sample Report @


Some of the key highlights of the Attention deficit hyperactivity disorder Market Report

The Centers for Disease Control and Prevention (CDC) suggests that the estimated number of children diagnosed with ADHD, according to a national 2016 parent survey, were 1 is 6.1 million (9.4%). This number includes 388,000 children aged 2–5 years, 4 million children aged 6–11 years and 3 million children aged 12–17 years. Furthermore, the CDC also highlights the fact that boys are more likely to be diagnosed with ADHD than girls (12.9% compared to 5.6%).
As per the ADHD Institute, a mean worldwide prevalence of 2.2% (range: 0.1–8.1%) of ADHD has been estimated in children and adolescents (aged
According to DelveInsight’s analysis, adult males have more diagnosed proportion of ADHD cases than females.
As per a study conducted by Catalá-López et al. titled “Prevalence of attention deficit hyperactivity disorder among children and adolescents in Spain: a systematic review and meta-analysis of epidemiological studies”, the overall pooled-prevalence of ADHD was estimated to be 6.8% (4.9–8.8%), representing 361,580 (260,550–467,927) children and adolescents in the community among 13,026 subjects that were considered for the study.


Attention deficit hyperactivity disorder Epidemiology Insights

As per the National Survey of Children’s Health (NSCH) 2003–2011, 5.1 million children (8.8% or 1 in 11 of the age group 4–17 years) were diagnosed with ADHD in the United States. Out of this, 6.8%, 11.4% and 10.2% of children belong to the age groups 4–10 (1 in 15), 11–14 (1 in 9) and 15–17 (1 in 10), respectively. Additionally, the data gathered through this survey also indicated that boys (12.1%) continued to be more than twice as likely as girls (5.5%) to have ADHD.


Attention deficit hyperactivity disorder Epidemiology Segmentation

Total Attention deficit hyperactivity disorderDiagnosed Prevalent cases
Attention deficit hyperactivity disorderGender-specific Diagnosed Prevalent Cases
Attention deficit hyperactivity disorderGender-specific Diagnosed Prevalent Cases in children
Attention deficit hyperactivity disorderSubtype-specific Diagnosed Prevalent Cases


Download Free Sample Report Now @


Attention deficit hyperactivity disorder Symptoms

ADHD Symptoms tend to be noticed at an early age and may become more noticeable when a child’s circumstances change, such as when they start school. Most cases are diagnosed when children are 6 to 12 years old. The symptoms of ADHD usually improve with age, but many adults who were diagnosed with the condition at a young age continue to experience problems. People with ADHD may also have additional problems, such as sleep and anxiety disorders.


Attention deficit hyperactivity disorder Cause

The exact cause of ADHD is still not known. Like many other illnesses, several factors can contribute to ADHD, such as genes, cigarette smoking, alcohol use, or drug use during pregnancy, exposure to environmental toxins during pregnancy, exposure to environmental toxins, such as high levels of lead, at a young age, low birth weight or brain injuries.


Attention deficit hyperactivity disorder Diagnosis

Diagnosing ADHD in children depends on a set of strict criteria. To be diagnosed with ADHD, pediatric patient must have 6 or more symptoms of inattentiveness, or 6 or more symptoms of hyperactivity and impulsiveness.


Attention deficit hyperactivity disorder Treatment Market

Attention deficit hyperactivity disordercan be treated using medicine or therapy, but a combination of both is often best. Medications can affect patients differently and can have side effects such as decreased appetite or sleep problems. Certain patients may respond well to one medication, but not to another. Furthermore, supplements may also be recommended to patients suffering from ADHD.


Attention deficit hyperactivity disorder Market Insights

There are certain class of medicines that have been licensed for the treatment of ADHD, which includes methylphenidate, dexamfetamine, lisdexamfetamine, atomoxetine and guanfacine. These medicines are not a permanent cure for ADHD but may help patients with the condition concentrate better, be less impulsive, feel calmer, and learn and practice new skills.


View Detailed Research Report Here @


Attention deficit hyperactivity disorder Emerging Therapy Assessment

The expected launch of emerging therapy such as SPN-812, Centanafadine, KP415, KP484, and others is expected to change the treatment landscape of ADHD in the upcoming years.


Attention deficit hyperactivity disorder Market Drivers

Robust Pipeline Activity
Constructive Efforts
Increased public awareness


Attention deficit hyperactivity disorder Market Barriers

Comorbid Conditions


Table of content

1. Key Insights

2. Executive Summary

3. Competitive Intelligence Analysis

4. Market Overview at a Glance

5. Disease Background and Overview

6. Patient Journey

7. Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Attention-deficit/hyperactivity disorder (ADHD) Treatment

11. Marketed Products

12. Emerging Therapies

13. Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight


Consult with our Business Expert @


About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States